Cary Street Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
14,914
-1,383
-8% -$123K 0.03% 412
2026
Q1
$1.17M Buy
16,297
+2,673
+20% +$206K 0.03% 418
2025
Q4
$1.08M Buy
13,624
+3,708
+37% +$292K 0.03% 423
2025
Q3
$748K Sell
9,916
-1,012
-9% -$69.4K 0.02% 488
2025
Q2
$754K Sell
10,928
-1,338
-11% -$87.7K 0.02% 461
2025
Q1
$831K Sell
12,266
-2,148
-15% -$129K 0.03% 429
2024
Q4
$647K Buy
+14,414
New +$809K 0.02% 460

Other funds holding CVS

Cary Street Partners's CVS Position: Q2 2026 in Review

Cary Street Partners reduced its CVS Health (CVS) stake by 8.5% in Q2 2026, selling an estimated $123K and leaving 14,914 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #412.

Cary Street Partners first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Cary Street Partners held 14,914 shares of CVS Health worth $1.54M as of Q2 2026.
  • Cary Street Partners sold 1,383 CVS Health shares in Q2 2026, an estimated $123K.
  • CVS Health made up 0.03% of Cary Street Partners's portfolio in Q2 2026, its #412 holding.
  • Cary Street Partners first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.